Contribution of anti-cyclic citrullinated peptide antibody and rheumatoid factor to the diagnosis of arthropathy in haemochromatosis - Aigner, E; Schmid, I; Österreicher, C H; Zwerina, J; Schett, G; Strasser, M; Niksic, F; Hohla, F; Ramsauer, T; Dorn, U; Patsch, W; Datz, C (Annals of the rheumatic diseases, 2007)
Keywords: ACR; Adolescent; Adult; Aged; American College of Rheumatology; anti-CCP; Arthritis, Rheumatoid - diagnosis; Arthritis, Rheumatoid - immunology; arthropathy; Autoantibodies - blood; Biological and medical sciences; Biomarkers - blood; Case-Control Studies; CCP; Chi-Square Distribution; Concise Report; cyclic citrullinated peptide antibodies; Diagnosis, Differential; Diseases of the osteoarticular system; Enzyme-Linked Immunosorbent Assay; Female; haemochromatosis; Health risk assessment; Hemochromatosis - blood; Hemochromatosis - complications; Hemochromatosis - immunology; Hemochromatosis Protein; hereditary haemochromatosis; HHC; Histocompatibility Antigens Class I - genetics; Homozygote; Humans; Inflammatory joint diseases; Joint Diseases - blood; Joint Diseases - etiology; Joint Diseases - immunology; Male; Medical sciences; Membrane Proteins - genetics; Metabolic diseases; Metals (hemochromatosis...); Middle Aged; Miscellaneous. Osteoarticular involvement in other diseases; Mutation; Other metabolic disorders; Patients; Peptides, Cyclic - immunology; Point Mutation; Prevalence; Rheumatism; Rheumatoid arthritis; rheumatoid factor; Rheumatoid Factor - blood; Sensitivity and Specificity; Human; Immunopathology; Hemochromatosis; Peptides; Antibody; Diseases of the osteoarticular system; Autoimmune disease; Metabolic diseases; Inflammatory joint disease; Arthritis; Iron; Joint; Enzymopathy; Rheumatoid factor; Chronic; Rheumatoid arthritis; Arthropathy; Diagnosis; ELISA assay